Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanhuang Fukang Oil for acute radiation dermatitis in breast cancer radiotherapy
ChiCTR1900026121Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Oct 2019
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Sanhuang Fukang Oil in radiodermatitis (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Evaluation of skin lesion classification of acute radiation dermatitis. Started Oct 2019; status: recruiting.
02
Drugs
Sanhuang Fukang Oil
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on ChiCTR1900026121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026121.